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Here we report for the first time the design and expression of highly charged, unfolded protein
polymers based on elastin-like peptides (ELPs). Positively and negatively charged variants were
achieved by introducing lysine and glutamic acid residues, respectively, within the repetitive
pentapeptide units. Subsequently it was demonstrated that the monodisperse protein polyelec-
trolytes with precisely defined amino acid compositions, sequences, and stereochemistries can
be transferred into superstructures exploiting their electrostatic interactions. Hollow capsuleswere
assembled from oppositely charged protein chains by using the layer-by-layer technique. The
structures of the capsuleswere analyzed
by various microscopy techniques
revealing the fabrication of multilayer
containers. Due to their low toxicity in
comparison to other polyelectrolytes,
supercharged ELPs are appealing candi-
dates for the construction of electrosta-
tically induced scaffolds in biomedicine.
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Genetically encoded polypeptides with repetitive motifs
have gained increasing attention in recent years due to their
high potential for biotechnological and biomedical applica-
tions. This development was mainly fueled by progress in
recombinant DNA technology allowing precise control of
the structure of the resulting macromolecules.[1,2] Impor-
tant examples are silk-like,[3] collagen-like[4,5], and elastin-
like proteins (ELPs).[6] The latter are derived from a repeating
motif within a hydrophobic domain of mammalian
tropoelastin. The most common pentapeptide motif has
the sequence (VPGXG)n with X being any guest amino acid
except proline andn denoting the number of repeats.[7] The
structural and physical properties of ELPs, such as their
elastic/mechanical as well as thermoresponsive behavior,
have been investigated.[8–10] Their ability to undergo a
reversible phase transition at the so-called lower criticallibrary.com DOI: 10.1002/marc.201000491
Figure 1. Purified ELP variants K48 and E57 examined by SDS-PAGE.
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www.mrc-journal.desolution temperature (LCST) has been exploited for the
purification of proteins[11] and DNA.[12] For tissue engineer-
ing purposes, ELPs were designed as thermally sensitive
hydrogels that solidify when injected into the body.[13]
Furthermore, their temperature responsiveness was
utilized for drug delivery applications. In hyperthermia
treatment, ELPs were accumulated in tumors[14] and the
LCST-behavior was employed to induce micelle formation
of block ELP structures.[15](a) 4–12% NuPAGE1 gel stained with SimplyBlueTM safe stain.
K48: 2mg, E57: 8mg. (b) 12% SDS-PAGE gel stained with a 0.3 M
copper (II) chloride solution. K48: 2mg, E57: 4mg.
Figure 2. Schematic illustration of the multiple assembly of the
two oppositely supercharged proteins onto spherical CaCO3 por-
ous microparticles via LbL assembly technique, and fabrication of
a hollow protein-based capsule by dissolution of the template
core. The turquoise lines represent the supercharged negative E57
ELP, the violet lines represent the supercharged positive K48 ELP.
For simplicity, only two layers are shown. Capsules are not drawn
to scale.Results and Discussion
Design, Preparation, and Characterization of
Elastin-like Polypeptides (ELPs)
The choice of different guest amino acids within the ELP
motif allows the precise control of LCST and the incorpora-
tion of chemical modifications.[16] Here, we took advantage
of the flexibility of amino acid composition at the fourth
position within the repeat to transform ELPs into unpre-
cedented highly charged anionic and cationic polyelec-
trolytes. These structures of biosynthetic origin are much
better defined than their chemically synthesized counter-
parts. To assess their viability in a common application
for polyelectrolytes in a biomedical context, these
materials were transformed into superstructures, i.e.,
hollow capsules, employing the electrostatic interactions
of oppositely charged variants.
We thus decided to introduce lysine and glutamic acid
residues in order to obtain highly positively and negatively
charged polypeptide chains, respectively. Monomer units of
the ELP gene encoded ten pentapeptide repeats (Val-Pro-
Gly-Lys/Glu-Gly) and were multimerized using recursive
directional ligation, as described by Meyer and Chilkoti.[10]
ELPs with 48 positive (K48) or 57 negative (E57) charges
were produced in E. coli and purified (Supporting Informa-
tion). Protein yields were 1 and 5 mg per liter of bacterial cell
culture for K48 and E57, respectively. The purity of the
products was analyzed by polyacrylamide gel electrophor-
esis and subsequent staining with either SimplyBlueTM
SafeStain (Invitrogen) or copper(II) chloride (Figure 1). ELPs
exhibited reduced electrophoretic mobilities compared to
globular proteins, a finding widely observed with ELPs.[10] It
was also observed that the negatively charged variant E57
was poorly stained with the SimplyBlue SafeStain as well as
with Coomassie brilliant blue R-250 (data not shown).
Staining with copper(II) chloride, however, led to a clear E57
protein band and a white K48 protein band against an
opaque, whitish-blue background (Figure 1b). Analysis of
the purified ELPs by mass spectrometry resulted in
molecular weights that were in excellent agreement with
the theoretical values (see Supporting Information). As
expected,[17] the proteins K48 and E57 do not exhibit LCSTwww.MaterialsViews.com
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when dissolved in water (see Supporting Information).Capsule Preparation and Characterization
After successful expression our next goal was to exploit the
high net charges of K48 and E57 for self assembly of the ELP
variants into supramolecular structures, namely multilayer
polypeptide capsules, using a layer-by-layer (LbL) techni-
que[18] (Figure 2). This technique is based on the consecutive
assembly of oppositely charged polymers around a
preformed charged spherical template[18] with typical
diameter from a few hundred nm to a few mm. At the
end of the LbL adsorption process, the cores can be
successfully removed to obtain hollow and intact capsules.
Polymer containers based on the LbL technique have
recently attracted high interest for a variety of different
applications, ranging from drug delivery systems and
targeted gene therapy to biosensor devices.[19,20] To date,
capsules have been made of synthetic and biodegradable
polyelectrolytes,[21,22] comprising natural molecules such
as oligonucleotides[23] and proteins,[24,25] which demon-
strates the high versatility of LbL assembly.
Using standard LbL preparation techniques[18] and
employing supercharged proteins E57 and K48 as buildingn. 2011, 32, 186–190
H & Co. KGaA, Weinheim 187
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A. Kolbe et al.blocks, we generated capsules exhibiting the following
wall structure: (DEXS/pARG)(E57/K48)3(E57/K48AF488)E57,
where DEXS denotes dextran sulfate and pARG poly-
(L-arginine), two charged biodegradable polymers made
from naturally occurring monomers (see Supporting
Information). The use of DEXS/pARG as a first bi-layer
proved crucial to growing a stable multilayer (E57/K48)
wall, providing a barrier against diffusion of the proteins
into the porous CaCO3 particle templates (see Supporting
Information, Figure S6). For visualization purposes, one
layer of K48 was fluorescence labeled with Alexa AF488
(see Supporting Information). Capsules were characterized
with confocal laser scanning microscopy (CLSM), transmis-
sion electron microscopy (TEM), and scanning electron
microscopy (SEM).
In Figure 3 representative images of the capsules formed
by supercharged proteins are shown. These images clearly
demonstrate the existence of capsules with an empty
interior and stable walls. Notably, the dissolution of the core
is a critical step in the preparation of hollow capsules, as it
may result in capsules breaking or swelling due to
decomposition conditions (i.e., low pH) where the polymer
wall may disaggregate. In view of that, the results reported
in Figure 3 indicate that a hollow and stable wall remains
when the inorganic core is dissolved. Compared to capsules
formed by standard synthetic polyelectrolytes, such as
polystyrene sulfonate (PSS) and poly(allylamine hydro-
chloride) (PAH),[18] the walls of capsules based on super-
charged proteins are rather porous (see Supporting
Information, Figure S10, 12–13). This may be a result of
the lower charge density of E57 and K48 compared to PSS
and PAH (see Supporting Information, Table 1), which
results in a higher mechanical pressure during the
dissolution procedure. For instance, permeability tests
performed on (E57/K48) capsules without cores showed the
diffusion across the protein wall of the encapsulated
dextran (500 kDa MW) (see Supporting Information, FigureFigure 3. Structural analysis of capsules assembled by the supercharge
image of one capsule in aqueous solution whose wall had been labe
several capsules. Images demonstrate the particulate nature of the ca
performed in vacuum capsules collapse, indicating the absence of the
Macromol. Rapid Commun
 2011 WILEY-VCH Verlag GmbS10), thus indicating the formation of large pores in the
multilayer wall. This hypothesis was subsequently sup-
ported by TEM and SEM observation of capsules after core
dissolution (see Supporting Information, Figure S12,13).
At any rate, the two structural compartments of
capsules, cavity, and wall, are well defined and prove
successful and stable assembly (Supporting Information,
Figure S7 and S9).Evaluation of in vitro Cytotoxicity
Such capsules might be appealing containers for use in
biomedicine. Since positively charged polymers are the
most common source of toxicity in charged systems due to
their interaction with anionic intracellular compo-
nents,[26–28] the toxicity of K48 was investigated and
compared to the other positive polyelectrolytes used for
the synthesis of capsule controls (i.e., PLL, PAH, pARG). A
fluorimetric metabolic assay employing NIH/3T3 embryo-
nic fibroblast cells was utilized to assess cytotoxicity.
The normalized fluorescence of Resorufin, a dye indicating
metabolically active cells, was plotted against poly-
electrolyte concentrations (Figure 4). The resulting
dose response curves yielded the following polymer
concentrations causing 50% cell death (LD50, mg mL1)
in decreasing order of toxicity: PLL (LD50¼ 0.007),
PAH (LD50¼ 0.009), pARG (LD50¼ 0.015), and K48
(LD50¼ 0.196). PLL, PAH, and pARG exhibited similar
dose response curves with similar LD50 values, whereas
the curve for K48 was strongly shifted to higher
concentration values. This indicates that lower concentra-
tions of PLL, PAH, and pARG than of K48 are able to induce
cell death. K48 induces toxicity at the maximum
concentration value used (1 mg mL1) and this effect
was immediately mitigated by halving the dose. A plateau
level of viability was reached at a concentration of
3.1 102 mg mL1.d proteins E57 and K48 after removal of the template cores. (a) CLSM
led with Alexa Fluor 488. The inset shows a low resolution image of
psules. (b,c) TEM and SEM image of one capsule. As TEM and SEM are
template core and thus an empty cavity. Scale bars represent 1mm.
. 2011, 32, 186–190
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Figure 4. Comparison of the polyelectrolyte-induced toxicity on
NIH/3T3 embryonic fibroblasts. Cells were incubated with the
different polymers in a concentration range from 6.1 105 to
1 mg mL1 and some cells were left untreated as positive control
for viability. Cell viability was assessed by an increase in the
fluorescence signal and is given as mean of normalized inten-
sities. The normalized fluorescent intensity is plotted against the
concentration (c) and shows a sigmoidal concentration–toxicity
relationship. PLL: poly(L-lysine); PAH: poly(allylamine hydrochlo-
ride); pARG: poly(L-arginine).
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www.mrc-journal.deConclusion
In this work we demonstrated the expression of super-
charged polypeptides consisting of repetitive motifs. As a
result of incorporating a single charge per almost every
repeat, unfolded polyelectrolytes were obtained that are
perfectly defined regarding their number and distribution
of charges, monomer composition, stereochemistry, and
dispersity, which is almost impossible by conventional
polymerization techniques. With K48 for example, 1
positive charge per 5.7 amino acids was reached. ELPs with
charged amino acids as guest residues have already been
produced, but with much lower charge densities than
reported herein.[16] So far only a single-folded protein, green
fluorescent protein (GFP), was equipped with similar
amounts and densities of charges.[29] However, within
GFP the charges were by far not as equally distributed as in
the ELP backbone. In this respect we demonstrated that the
concept of supercharging by genetic engineering can be
extended to other peptide-based biopolymers. When
comparing supercharged ELPs with naturally occurring
polypeptides, we see that with K48 it was even possible to
realize a charge density comparable to only a few naturally
occurring unfolded proteins,[29,30] all while using a minimal
set of the amino acid alphabet.www.MaterialsViews.com
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these de novo designed proteins could be exploited for
the fabrication of supramolecular structures. Oppositely
charged variants were transformed into multilayer cap-
sules by electrostatic interactions employing the widely
used LbL technique. Due to their low toxicity, supercharged
proteins like the highly charged ELPs presented in this work
promise to be a favorable alternative to their chemically
synthesized counterparts in the context of biomedical
scaffolds. In the future we will employ supercharged ELPs
for the generation of other electrostatically induced
polymeric architectures such as polyplexes and hydrogels
with well defined network porosity.Acknowledgements: Parts of the project were supported by an
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